These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29176656)

  • 1. Clinical trials: Treatment of HCV-infected patients with advanced kidney disease.
    Ladino M; Roth D
    Nat Rev Nephrol; 2018 Jan; 14(1):6-8. PubMed ID: 29176656
    [No Abstract]   [Full Text] [Related]  

  • 2. HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs).
    La Manna G
    J Nephrol; 2018 Apr; 31(2):185-187. PubMed ID: 29411309
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatitis C in potential kidney and heart transplant patients.
    Fabrizi F; Bunnapradist S; Martin P
    Clin Liver Dis; 2005 Aug; 9(3):487-503, viii. PubMed ID: 16023979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of direct antiviral drugs in special patients with HCV infection].
    Jiang C; Liu CY; Shao S; Gao YH
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):316-320. PubMed ID: 29996347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline.
    Terrault NA
    Hepatology; 2018 Nov; 68(5):2035-2038. PubMed ID: 29672896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment in chronic renal failure].
    Curciarello J; Fernández JL; Silva M
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S55-7. PubMed ID: 20214305
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacotherapy of hepatitis C virus infection: a brief review.
    Quan DJ
    Nephrol Nurs J; 2009; 36(3):333-7. PubMed ID: 19588704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of sustained virologic response of HCV with telaprevir-based therapy in a patient with HIV and end stage kidney disease.
    Slim J; Scangarello N; Samaha P; Dazley J
    Int J STD AIDS; 2014 Oct; 25(11):830-2. PubMed ID: 24557545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.
    Naggie S; Muir AJ
    Annu Rev Med; 2017 Jan; 68():345-358. PubMed ID: 27686017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatitis C-related kidney disease.
    Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM
    Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hepatitis C virus coinfection in HIV-infected persons.
    O'Leary JG; Chung RT
    AIDS Read; 2006 Jun; 16(6):313-6, 318-20. PubMed ID: 16795921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus in the HIV-infected patient.
    Andersson K; Chung RT
    Clin Liver Dis; 2006 May; 10(2):303-20, viii. PubMed ID: 16971263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C infections in dialyzed patients].
    Podlasin RB
    Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection.
    Hsu YC; Ho HJ; Huang YT; Wang HH; Wu MS; Lin JT; Wu CY
    Gut; 2015 Mar; 64(3):495-503. PubMed ID: 25398770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C-Positive Kidney Transplant Recipients-When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
    Singh N; Dies D; Samant H
    Transplantation; 2017 May; 101(5):e192. PubMed ID: 28437390
    [No Abstract]   [Full Text] [Related]  

  • 18. Study results presented on interferon/ribavirin combination therapy.
    AIDS Read; 2001 Aug; 11(8):398. PubMed ID: 11570262
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of hepatitis C infection among patients with renal failure.
    Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delaying HCV treatment in HIV-positive patients.
    Carter M
    IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.